Form 8-K - Current report:
SEC Accession No. 0001144204-17-010488
Filing Date
2017-02-23
Accepted
2017-02-22 21:59:15
Documents
2
Period of Report
2017-02-21
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v460179_8k.htm 8-K 19154
2 EXHIBIT 16.1 v460179_ex16-1.htm EX-16.1 3560
  Complete submission text file 0001144204-17-010488.txt   23844
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 17630615
SIC: 2834 Pharmaceutical Preparations